Gastric atrophy, metaplasia, and dysplasia: a clinical perspective
- PMID: 12702963
- DOI: 10.1097/00004836-200305001-00006
Gastric atrophy, metaplasia, and dysplasia: a clinical perspective
Abstract
Gastric carcinoma of the intestinal type originates in dysplastic epithelium, which in turn develops in the milieu of atrophic gastritis and intestinal metaplasia. Cancers also may develop less often from gastric adenomatous polyps, which represent dysplastic epithelium arising in a raised lesion. The main causes of chronic atrophic gastritis and gastric atrophy are autoimmune due to pernicious anemia or chronic Helicobacter pylori infection. In the former condition, there is severe atrophy of the corpus (oxyntic mucosa), with the antrum being speared. In contrast, chronic atrophic gastritis consequent to H. pylori infection is a multifocal pangastritis, involving independent foci in the corpus and antrum of the stomach. For the most part, these clinical conditions are silent; the only manifestation of both these forms of chronic atrophic gastritis is cobalamin (vitamin B(12)) deficiency. In the case of the autoimmune gastritis of pernicious anemia, cobalamin deficiency results form the absence of intrinsic factor. When cobalamin deficiency occurs in patients with H. pylori-related gastritis, for the most part, it is because these patients have hypochlorhydria and are therefore unable to release cobalamin from its bound form in food. Patients may have advanced neuropsychiatric manifestations of cobalamin deficiency and yet not be anemic, have a normal blood smear, and even have serum cobalamin levels in the normal range. The condition may be identified by demonstrating elevated levels of homocysteine and methylmalonic acid. Intestinal metaplasia may be of the enteric (grade I), enterocolic (grade II), or colonic (grade III) type. Grade III intestinal metaplasia has traditionally been thought of as the most sinister variety, although the extent of atrophy and metaplasia may be a better marker for premalignancy than the mere identification of small areas of grade III intestinal metaplasia. Over the years, there has been much disagreement and a high degree of interrater variability, especially between Western and Japanese pathologists, as to the different grades of dysplasia and early gastric cancer. Recent consensus conferences at Vienna and Padova have resulted in better understanding of what constitutes these lesions, and it is hoped that in the near future agreement between pathologists will improve as a consequence. For the present, it is imperative that clinicians obtain second opinions from two or more expert pathologists on biopsy specimens before arriving at a diagnosis of either low- or high-grade dysplasia. The former histologic diagnosis is tantamount to subjecting the patient to endoscopic surveillance and the latter is tantamount to a decision regarding the resection of the lesion, both decisions being psychologically disturbing for patients. At this time, population screening for H. pylori is not recommended in Western countries, but most experts would agree that H. pylori should be eradicated if detected as part of the appropriate investigation of a clinical disorder such as dyspepsia. Certain other specific conditions may also be considered to be precancerous, such as the gastric remnant after a partial gastrectomy and the gastric mucosa in familial adenomatous polyposis syndrome and in familial Peutz-Jeghers syndrome and perhaps Ménétrier disease.
Similar articles
-
AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review.Gastroenterology. 2021 Oct;161(4):1325-1332.e7. doi: 10.1053/j.gastro.2021.06.078. Epub 2021 Aug 26. Gastroenterology. 2021. PMID: 34454714 Free PMC article. Review.
-
[Prevalence of Helicobacter pylori infection and gastric cancer precursor lesions in patients with dyspepsia].Arq Gastroenterol. 2007 Apr-Jun;44(2):93-8. doi: 10.1590/s0004-28032007000200002. Arq Gastroenterol. 2007. PMID: 17962851 Portuguese.
-
Incomplete intestinal metaplasia as an indicator for early detection of gastric carcinoma in the events of helicobacter pylori positive chronic atrophic gastritis.Bosn J Basic Med Sci. 2006 Nov;6(4):48-53. doi: 10.17305/bjbms.2006.3120. Bosn J Basic Med Sci. 2006. PMID: 17177650 Free PMC article.
-
Atrophy-metaplasia-dysplasia-carcinoma sequence in the stomach: a reality or merely an hypothesis?Best Pract Res Clin Gastroenterol. 2001 Dec;15(6):983-98. doi: 10.1053/bega.2001.0253. Best Pract Res Clin Gastroenterol. 2001. PMID: 11866488 Review.
-
Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia?Am J Gastroenterol. 2000 Jan;95(1):114-21. doi: 10.1111/j.1572-0241.2000.01609.x. Am J Gastroenterol. 2000. PMID: 10638568
Cited by
-
Efficacy and safety of Weifuchun tablet for chronic atrophic gastritis: A systematic review and meta-analysis.PLoS One. 2023 Apr 13;18(4):e0284411. doi: 10.1371/journal.pone.0284411. eCollection 2023. PLoS One. 2023. PMID: 37053262 Free PMC article.
-
Chinese integrated guideline on the management of gastric precancerous conditions and lesions.Chin Med. 2022 Dec 14;17(1):138. doi: 10.1186/s13020-022-00677-6. Chin Med. 2022. PMID: 36517854 Free PMC article. Review.
-
Gastric Mucosa Pathology in Rats with Precancerous Lesions of Gastric Cancer with Spleen Deficiency and Blood Stasis.Evid Based Complement Alternat Med. 2022 Sep 24;2022:1366597. doi: 10.1155/2022/1366597. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 36193144 Free PMC article.
-
Manpixiao Decoction Halted the Malignant Transformation of Precancerous Lesions of Gastric Cancer: From Network Prediction to In-Vivo Verification.Front Pharmacol. 2022 Aug 5;13:927731. doi: 10.3389/fphar.2022.927731. eCollection 2022. Front Pharmacol. 2022. PMID: 35991884 Free PMC article.
-
Use of folic acid supplementation to halt and even reverse the progression of gastric precancerous conditions: a meta-analysis.BMC Gastroenterol. 2022 Aug 2;22(1):370. doi: 10.1186/s12876-022-02390-y. BMC Gastroenterol. 2022. PMID: 35918654 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical